SODIUM THIOSULFATE

LOE Approaching

sodium thiosulfate

NDAINJECTIONINJECTABLE
Approved
Feb 1992
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
6

Clinical Trials (5)

NCT04983238Phase 1/2Completed

Evaluation of Safety and Efficacy of Sodium Thiosulfate (BYON5667) Eye Drops to Reduce Ocular Toxicity in Cancer Patients Treated With SYD985

Started Jan 2022
NCT00983398Phase 1/2Unknown

Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors

Started Jul 2009
17 enrolled
Central Nervous System Embryonal NeoplasmEmbryonal Tumor With Multilayered Rosettes, C19MC-AlteredGerm Cell Tumor+7 more
NCT00568399N/ACompleted

Sodium Thiosulfate Treatment of Vascular Calcification in ESRD

Started Dec 2007
48 enrolled
Complication of HemodialysisCardiovascular Diseases
NCT00303849Phase 1/2Completed

Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors

Started Sep 2005
33 enrolled
Anaplastic OligoastrocytomaAnaplastic OligodendrogliomaMixed Glioma+1 more
NCT00238173Phase 1Terminated

Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors

Started Dec 2004
2 enrolled
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ+1 more
Data Sources
  • Drug label: DailyMed / FDA
  • Clinical trials: ClinicalTrials.gov
  • Patent data: FDA Orange Book
  • Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.